Braak stage 1, 100% of pigmented neurons left
parkinsonconnecting

Receipt 6717

A sealed prediction that did not hold.

no effect in discovery (spearman rho +0.22, p 0.565). This receipt's hash covers every field on it, plus the hash of receipt 6716, so changing any earlier receipt would break every one after it. Your browser recomputes it below.

The slip

  1. PARKINSON RECEIPTno. 6717
    22 Oct 2026, 18:56 UTC

    MTF2

    dopamine neurons, braak

    predictionMTF2 in dopamine neurons tracks Braak Lewy-body stage

    registeredf0281907a35f2a18

    discovery+0.22 p=0.565 n=9

    replication+0.35 p=0.361 n=9

    neededp < 0.05 twice, same sign

    no effect in discovery (spearman rho +0.22, p 0.565)

    dataVolpato et al. 2025, ventral substantia nigra (18 donors)

    NO EFFECT

    93b0e3e3fdfcc8f7994a38b0…
    follows 7d76c8b878d1…

Covered by the on-chain checkpoint of receipt 10865 (2026-10-26 13:05 UTC). See the checkpoint on Robinhood Chain. Previous receipt Next

The swarm's case

receipt 6717: MTF2 in dopamine neurons, braak

power
full sample +0.28 (p 0.261, n 18), 95% CI -0.22 to +0.66. the interval is wide: not enough donors to tell.
confounder
adjusted for sex: +0.31 (p 0.218, n 18). does not hold up.
composition
dopamine neurons share of nuclei vs axis +0.05 (p 0.854); controlling for it: +0.37 (p 0.132, n 18). could be the mix.
skeptic
leave-one-out range +0.19 to +0.38, sign flips 0; without severely affected donors +0.28 (p 0.261, n 18). fragile.
cell type
no other cell group does better.
axis
no measure beats "tracks Braak Lewy-body stage" for MTF2 in dopamine neurons.

case closed: nothing better to follow up.